Jazz Pharmaceuticals plc
JAZZ · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $560,120 | $414,832 | -$224,060 | -$329,668 |
| Dep. & Amort. | $660,067 | $638,696 | $629,471 | $552,483 |
| Deferred Tax | -$208,327 | -$260,217 | -$292,251 | $69,198 |
| Stock-Based Comp. | $248,045 | $226,841 | $221,996 | $189,006 |
| Change in WC | -$76,720 | -$204,439 | $9,905 | -$47,952 |
| Other Non-Cash | $212,723 | $276,294 | $926,916 | $345,440 |
| Operating Cash Flow | $1,395,908 | $1,092,007 | $1,271,977 | $778,507 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$38,070 | -$23,962 | -$498,194 | -$27,641 |
| Net Acquisitions | $0 | $0 | $53,000 | -$6,234,792 |
| Inv. Purchases | -$1,305,125 | -$390,100 | -$61,036 | -$26,819 |
| Inv. Sales/Matur. | $845,000 | $270,000 | $60,000 | $1,095,000 |
| Other Inv. Act. | -$10,000 | -$19,000 | $0 | -$17,891 |
| Investing Cash Flow | -$508,195 | -$163,062 | -$446,230 | -$5,212,143 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $374,767 | -$31,000 | -$582,014 | $3,870,863 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$311,429 | -$269,761 | -$54 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$42,822 | -$4,493 | $52,577 | $99,659 |
| Financing Cash Flow | $20,516 | -$305,254 | -$529,491 | $3,970,522 |
| Forex Effect | -$1,675 | $1,137 | -$6,222 | -$3,207 |
| Net Chg. in Cash | $906,554 | $624,828 | $290,034 | -$466,321 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,506,310 | $881,482 | $591,448 | $1,057,769 |
| End Cash | $2,412,864 | $1,506,310 | $881,482 | $591,448 |
| Free Cash Flow | $1,347,838 | $1,068,045 | $773,783 | $732,975 |